Aflac Incorporated (AFL)

Market Cap	57.62B -4.7%
Revenue (ttm)	18.07B +13.6%
Net Income	4.86B +99.5%
EPS	9.37 +111.6%
Shares Out	501.34M
PE Ratio	12.03
Forward PE	15.37
Dividend	$2.44 (2.12%)
Ex-Dividend Date	Aug 19, 2026

Volume	2,087,290
Open	112.77
Previous Close	112.74
Day's Range	112.47 - 115.72
52-Week Range	105.43 - 130.22
Beta	0.56
Analysts	Hold
Price Target	118.13 (+2.78%)
Earnings Date	Nov 4, 2026

About AFL

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final ...

• Industry: Insurance - Life
• Sector: Financials
• Founded: 1955
• Employees: 12,716
• Stock Exchange: NYSE
• Ticker Symbol: AFL
• Website: https://www.aflac.com

Financial Performance

In 2025, Aflac's revenue was $17.16 billion, a decrease of -9.31% compared to the previous year's $18.93 billion. Earnings were $3.65 billion, a decrease of -33.01%.

Analyst Summary

According to 15 analysts, the average rating for AFL stock is "Hold." The 12-month stock price target is $118.13, which is an increase of 2.78% from the latest price.

Price Target

$118.13

(2.78% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 8, 2026

Data Sources Report a data error